Ambisome
Showing 1 - 25 of 68
Invasive Fungal Infections, Neutropenic Fever Trial in Seoul (AmBisome, DKF-5122)
Completed
- Invasive Fungal Infections
- Neutropenic Fever
- AmBisome
- DKF-5122
-
Seoul, Seocho-gu, Korea, Republic ofThe Catholic University of Korea Seoul St. Mary's Hospital
Feb 26, 2023
Bioequivalence Trial in Haikou (Amphotericin B liposome for injection, AmBisome)
Active, not recruiting
- Bioequivalence
- Amphotericin B liposome for injection
- AmBisome
-
Haikou, Hainan, ChinaHaikou people's Hospital
Jun 12, 2023
Chronic Pulmonary Aspergillosis Trial in Poitiers (inhaled Ambisome®, inhaled , Itraconazole)
Recruiting
- Chronic Pulmonary Aspergillosis
- inhaled Ambisome®
- +2 more
-
Poitiers, FranceCHU Poitiers
Feb 9, 2022
Cryptococcal Meningitis Trial in Kampala (Single dose liposomal Amphotericin and Fluconazole, Fluconazole)
Recruiting
- Cryptococcal Meningitis
- Single dose liposomal Amphotericin and Fluconazole
- Fluconazole
-
Kampala, Ugandainfectious Disease Institute Kampala,Uganda
Dec 21, 2022
Bioequivalence Trial in Wuhan (Amphotericin B liposome for injection, AmBisome®)
Completed
- Bioequivalence
- Amphotericin B liposome for injection
- AmBisome®
-
Wuhan, Hubei, ChinaWuhan Medical Treatment Center
Jul 28, 2021
Primary Visceral Leishmaniasis Trial (LXE408, Placebo, AmBisome®)
Not yet recruiting
- Primary Visceral Leishmaniasis
- LXE408
- +2 more
- (no location specified)
Oct 20, 2022
Morbid Obesity Trial in Nijmegen, Nieuwegein (Administration of study drug)
Completed
- Morbid Obesity
- Administration of study drug
-
Nijmegen, Gelderland, Netherlands
- +1 more
Oct 16, 2020
Allergic Bronchopulmonary Aspergillosis Trial in Poitiers (Liposomal amphotericin B (Ambisome®), )
Completed
- Allergic Bronchopulmonary Aspergillosis
- Liposomal amphotericin B (Ambisome®)
- placebo
-
Poitiers, FranceChu de Poitiers
Jun 8, 2020
Invasive Pulmonary Aspergillosis Trial in Madrid (Amphotericin B Liposomal 50 MG, Placebo)
Recruiting
- Invasive Pulmonary Aspergillosis
- Amphotericin B Liposomal 50 MG
- Placebo
-
Madrid, SpainJesus Fortun
Feb 2, 2021
Cryptococcal Meningitis, HIV Trial in Worldwide (Fluconazole, Amphotericin B)
Completed
- Cryptococcal Meningitis
- HIV Infections
- Fluconazole
- Amphotericin B
-
Los Angeles, California
- +9 more
Nov 2, 2021
PKDL - Post-Kala-Azar Dermal Leishmanioid Trial in Doka (Paromomycin, Ambisome, Miltefosine)
Unknown status
- PKDL - Post-Kala-Azar Dermal Leishmanioid
- Paromomycin
- +2 more
-
Doka, Gedaref, SudanProf. Elhassan Centre for tropical Medicine
Jan 15, 2020
Visceral Leishmaniasis Trial in Dhaka, Muzaffarpur, Patna (Amphotericin B Liposome, AmBisome (Amphotericin B) Liposome)
Completed
- Visceral Leishmaniasis
- Amphotericin B Liposome
- AmBisome (Amphotericin B) Liposome
-
Dhaka, Bangladesh
- +2 more
Aug 22, 2019
Visceral Leishmaniasis Trial in Abdurafi, Gondar (Liposomal Amphotericin B, Miltefosine)
Completed
- Visceral Leishmaniasis
- Liposomal Amphotericin B
- Miltefosine
-
Abdurafi, Ethiopia
- +1 more
Apr 4, 2019
Azole Resistance in A. Fumigatus to Improve Patient Outcome.
Completed
- Aspergillosis, Invasive Pulmonary
- PCR based detection of azole resistance in A. fumigatus
-
Amsterdam, Netherlands
- +7 more
Mar 22, 2022
Mucosal Leishmaniasis Trial in Santa Cruz de la Sierra (Group 1: Miltefosine, Group 2: Pentavalent Antimony, Group 3: Liposomal
Recruiting
- Mucosal Leishmaniasis
- Group 1: Miltefosine
- +2 more
-
Santa Cruz de la Sierra, SC, BoliviaHospital Dermatologico de Jorochito
Jun 14, 2022
Aspergillosis Trial in Singapore (behavioral, other, drug)
Completed
- Aspergillosis
- Galactomannan antigen monitoring, Aspergillus PCR
- +5 more
-
Singapore, SingaporeSingapore General Hospital
Sep 24, 2018
Leishmaniasis Trial in Washington (Sodium Stibogluconate (SSG))
Completed
- Leishmaniasis
- Sodium Stibogluconate (SSG)
-
Washington, District of ColumbiaWalter Reed Army Medical Center
Feb 10, 2021
Post-kala-azar Dermal Leishmaniasis Trial (AmBisome)
Completed
- Post-kala-azar Dermal Leishmaniasis
- AmBisome
- (no location specified)
Oct 11, 2017
Central Line Fungal Infections Trial in Pittsburgh (amphotericin B liposomal (Ambisome))
Completed
- Central Line Fungal Infections
- amphotericin B liposomal (Ambisome)
-
Pittsburgh, PennsylvaniaChildren's Hospital of Pittsburgh
Sep 10, 2017
Leishmaniasis Trial in Washington (Sodium Stibogluconate (SSG))
Completed
- Leishmaniasis
- Sodium Stibogluconate (SSG)
-
Washington, District of ColumbiaWalter Reed National Military Medical Center
Dec 30, 2019
Diagnoses That Require Stem Cell Transplant, GVHD (GVHD) Trial in Cincinnati (Maraviroc)
Terminated
- Diagnoses That Require Stem Cell Transplant
- Graft Versus Host Disease (GVHD)
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Mar 2, 2020
Primary Visceral Leishmaniasis Trial in Kimalel, Kassab, Doka (Liposomal amphotericin B (AmBisome®) and sodium stibogluconate,
Completed
- Primary Visceral Leishmaniasis
- Liposomal amphotericin B (AmBisome®) and sodium stibogluconate
- +2 more
-
Kimalel, Kenya
- +2 more
Apr 21, 2017
Visceral Leishmaniasis Trial in Brazil (Antimoniate of N-methylglucamine, amphotericin B deoxycholate, Liposomal amphotericin B)
Terminated
- Visceral Leishmaniasis
- Antimoniate of N-methylglucamine
- +2 more
-
Sergipe, Aracaju, Brazil
- +4 more
Aug 31, 2017